189 related articles for article (PubMed ID: 29658331)
1. Patients' exposure to PVC plasticizers from ECMO circuits.
Fernandez-Canal C; Pinta PG; Eljezi T; Larbre V; Kauffmann S; Camilleri L; Cosserant B; Bernard L; Pereira B; Constantin JM; Grimandi G; Sautou V;
Expert Rev Med Devices; 2018 May; 15(5):377-383. PubMed ID: 29658331
[TBL] [Abstract][Full Text] [Related]
2. Exposure of patients to di(2-ethylhexy)phthalate (DEHP) and its metabolite MEHP during extracorporeal membrane oxygenation (ECMO) therapy.
Kaestner F; Seiler F; Rapp D; Eckert E; Müller J; Metz C; Bals R; Drexler H; Lepper PM; Göen T
PLoS One; 2020; 15(1):e0224931. PubMed ID: 31999712
[TBL] [Abstract][Full Text] [Related]
3. Plasticizer di(2-ethylhexyl)phthalate (DEHP) release in wet-primed extracorporeal membrane oxygenation (ECMO) circuits.
Han J; Beeton A; Long P; Karimova A; Robertson A; Cross N; Smith L; O'Callaghan M; Goldman A; Brown K; Tuleu C
Int J Pharm; 2005 Apr; 294(1-2):157-9. PubMed ID: 15814240
[TBL] [Abstract][Full Text] [Related]
4. Analytical methods for the determination of DEHP plasticizer alternatives present in medical devices: a review.
Bernard L; Décaudin B; Lecoeur M; Richard D; Bourdeaux D; Cueff R; Sautou V;
Talanta; 2014 Nov; 129():39-54. PubMed ID: 25127563
[TBL] [Abstract][Full Text] [Related]
5. The effect of priming solutions and storage time on plasticizer migration in different PVC tubing types--implications for wet storage of ECMO systems.
Horne DC; Torrance I; Modine T; Gourlay T
J Extra Corpor Technol; 2009 Dec; 41(4):199-205. PubMed ID: 20092073
[TBL] [Abstract][Full Text] [Related]
6. Presence of plasticizer di-2(ethylhexyl)phthalate in primed extracorporeal circulation circuits.
Burkhart HM; Joyner N; Niles S; Ploessl J; Everett J; Iannettoni M; Richenbacher W
ASAIO J; 2007; 53(3):365-7. PubMed ID: 17515730
[TBL] [Abstract][Full Text] [Related]
7. [Safety assessment of DEHP from PVC medical devices].
Yang X
Zhongguo Yi Liao Qi Xie Za Zhi; 2012 Mar; 36(2):118-20. PubMed ID: 22737892
[TBL] [Abstract][Full Text] [Related]
8. Effect of phospholipid coating on the migration of plasticizers from PVC tubes.
Münch F; Höllerer C; Klapproth A; Eckert E; Rüffer A; Cesnjevar R; Göen T
Chemosphere; 2018 Jul; 202():742-749. PubMed ID: 29604561
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxic effects of DEHP-alternative plasticizers and their primary metabolites on a L929 cell line.
Eljezi T; Pinta P; Richard D; Pinguet J; Chezal JM; Chagnon MC; Sautou V; Grimandi G; Moreau E
Chemosphere; 2017 Apr; 173():452-459. PubMed ID: 28129623
[TBL] [Abstract][Full Text] [Related]
10. The safety of medical devices containing DEHP plasticized PVC or other plasticizers on neonates and other groups possibly at risk (2015 update).
Testai E; ; Hartemann P; Rastogi SC; Bernauer U; Piersma A; De Jong W; Gulliksson H; Sharpe R; Schubert D; Rodríguez-Farre E;
Regul Toxicol Pharmacol; 2016 Apr; 76():209-10. PubMed ID: 26854686
[No Abstract] [Full Text] [Related]
11. Extracorporeal membrane oxygenation exposes infants to the plasticizer, di(2-ethylhexyl)phthalate.
Karle VA; Short BL; Martin GR; Bulas DI; Getson PR; Luban NL; O'Brien AM; Rubin RJ
Crit Care Med; 1997 Apr; 25(4):696-703. PubMed ID: 9142038
[TBL] [Abstract][Full Text] [Related]
12. Migrability of PVC plasticizers from medical devices into a simulant of infused solutions.
Bernard L; Cueff R; Breysse C; Décaudin B; Sautou V;
Int J Pharm; 2015 May; 485(1-2):341-7. PubMed ID: 25796128
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on the migration of di-2-ethylhexyl phthalate (DEHP) and tri-2-ethylhexyl trimellitate (TOTM) into blood from PVC tubing material of a heart-lung machine.
Eckert E; Münch F; Göen T; Purbojo A; Müller J; Cesnjevar R
Chemosphere; 2016 Feb; 145():10-6. PubMed ID: 26650574
[TBL] [Abstract][Full Text] [Related]
14. Health risks posed by use of Di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review.
Tickner JA; Schettler T; Guidotti T; McCally M; Rossi M
Am J Ind Med; 2001 Jan; 39(1):100-11. PubMed ID: 11148020
[TBL] [Abstract][Full Text] [Related]
15. [Application and Safety Evaluation of DEHP in PVC Medical Devices].
Wang Y; Xie X; Jiang H; Wang J
Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Jul; 42(4):293-295. PubMed ID: 30112899
[TBL] [Abstract][Full Text] [Related]
16. Experimental study on infusion devices containing polyvinyl chloride: to what extent are they di(2-ethylhexyl)phthalate-free?
Genay S; Luciani C; Décaudin B; Kambia N; Dine T; Azaroual N; Di Martino P; Barthélémy C; Odou P
Int J Pharm; 2011 Jun; 412(1-2):47-51. PubMed ID: 21497186
[TBL] [Abstract][Full Text] [Related]
17. New SPE-LC-MS/MS method for the simultaneous determination in urine of 22 metabolites of DEHP and alternative plasticizers from PVC medical devices.
Pinguet J; Kerckhove N; Eljezi T; Lambert C; Moreau E; Bernard L; Boeuf B; Decaudin B; Genay S; Masse M; Storme L; Sautou V; Richard D;
Talanta; 2019 Jun; 198():377-389. PubMed ID: 30876575
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory response of rat and human neutrophils exposed to di-(2-ethyl-hexyl)-phthalate-plasticized polyvinyl chloride.
Gourlay T; Samartzis I; Stefanou D; Taylor K
Artif Organs; 2003 Mar; 27(3):256-60. PubMed ID: 12662212
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the direct toxicity of trioctyltrimellitate (TOTM), di(2-ethylhexyl) phthalate (DEHP) and their hydrolysis products on isolated rat hepatocytes.
Kambia K; Dine T; Gressier B; Dupin-Spriet T; Luyckx M; Brunet C
Int J Artif Organs; 2004 Nov; 27(11):971-8. PubMed ID: 15636055
[TBL] [Abstract][Full Text] [Related]
20. In vitro cytotoxic effects of secondary metabolites of DEHP and its alternative plasticizers DINCH and DINP on a L929 cell line.
Eljezi T; Pinta P; Nativel F; Richard D; Pinguet J; Roy O; Sautou V; Grimandi G; Moreau E
Int J Hyg Environ Health; 2019 Apr; 222(3):583-589. PubMed ID: 30898526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
